Navigation Links
Tea drinkers have lower rates of heart disease

In comparison to coffee, tea drinkers have lower rates of heart disease and cancer, although few clinical studies have been done. Doctors are carrying out research into the effect of green tea in men with prostate cancer. They hope it will be just one of the many studies that will be done on the benefits of tea.// Generally tea drinkers are less likely to have heart disease or cancer, although the reason is still unknown.

One likely reason is the high levels of antioxidants in tea. Antioxidants, found also in fruits and vegetables, mop up the harmful free radicals produced by the body's chemistry.

Left unchecked, free radicals damage cell components like DNA and protein molecules, causing cancer. Black, green and oolong tea all come from the same bush - known as Camellia sinensis - which is known to carry a high level of flavonoids, one of the most potent types of antioxidants.


'"/>




Page: 1

Related medicine news :

1. Wine drinkers may have reasons to cheer
2. Good news for moderate alcohol drinkers!
3. It is the old drinkers than binge drinkers who are at risk of ill health
4. Good drinkers have Higher Risk of Alcoholism
5. Spouses and other partners lower blood pressure says new research
6. Brisk Walking lowers memory loss in women
7. B Vitamin protects and lowers toxicity of Arthritis Drug
8. Estrogen lowers cancer risk
9. Lecithin lowers cholesterol absorption in body
10. Salt reduction lowers blood pressure
11. Exercise lowers Risk of Ovarian Cancer
Post Your Comments:
(Date:7/9/2008)...etic outcome after lumpectomy linked to depression...9 (HealthDay News) -- A third of women who opt for...e an asymmetry between their breasts that greatly ..., Women whose affected breast looked noticeably ...ar their cancer returning and to have symptoms of ...
(Date:7/9/2008)...ship Integrates In-Store and Online Marketing to C...erience, PITTSBURGH and NEW YORK, July 9 /PRNewsw..."GNC"), the largest global specialty retailer of,n...he leading source of,health information, today ann...ase consumer awareness and understanding of the im...
(Date:7/9/2008)...LAS and PLANO, Texas, July 9 /PRNewswire/ -- SKINT... is pleased to announce the arrival,of newly FDA-a...gen filler,in the Skintastic arsenal of little-or-...s immediate, predictable visible results, with lit...orted with EVOLENCE(R) in a,comparison study again...
(Date:7/9/2008)... DRE, Inc., a premier international...its customers that as much as $250,000 in medical ...me tax filings. , Louisvi...lus Act of 2008, in accordance with Tax Code Secti... equipment bought in 2008. This could make 2008 an...
Breaking Medicine News(10 mins):Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:New Injectable Collagen Filler Offers Natural Results 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...l study found that the use of Herceptin in advance... of cardiac toxicity − nearly 28 percent of ...ical trial has yet reported;The silver lining is t...be remedied with treatment. The study, published...
...open-heart surgery was performed on a 17 yr old bo...spital// (TMCH). An eight-member team led by card...ery on the boy who was suffering from an arterial ...n the 4th of August. Dr S Balakrishnan the dean ...
...undergo surgery following an early pregnancy failu...under general anesthesia//. However a new study ha... approach. Early pregnancy failure - or EPF - occ...ognized pregnancies. Cases treated with surgery ty...
...ularity of unpasteurized milk has raised questions...ple consume unpasteurized milk for a variety of re...asteurized milk are healthier and tastier, it can’...me it do fall sick. There been have instances whe...
Other Medicine News:Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 2Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 3Health News:Women Prefer Office Procedure during treatment of Early Pregnancy 2Health News:Women Prefer Office Procedure during treatment of Early Pregnancy 3
(Date:7/7/2008)...Newswire-FirstCall/ -- Pulmo BioTech Inc. (OTC,Bul...diary, PulmoScience,Inc. has completed the bio-dis...for the PulmoBind technology of Molecular Imaging ...maging uses a molecule designed to bond specifical...lmoBind, the chosen molecule,was designed to bond ...
(Date:7/7/2008)...ewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulle...d biopharmaceutical,company specializing in the pr...ay provided an operational update on the company,s...man clinical trial testing and,plans to proceed in... Five,successful human trials evaluating GeoVax AI...
(Date:7/7/2008)...July 7 /- The Leukemia & Lymphoma,Soc...dberg M.D., M.M.Sc.,of the James P. Wilmot Cancer...ter. Millennium Pharmaceuticals, The Takeda Oncolo...rst two years of the five-year program., The Scho...will support,Dr. Friedberg,s work on a new targete...
(Date:7/6/2008)...TI,s Marketing Authorization Application currently... SEATTLE, July 7 /- Cell Th... announced the publication of results from its,ran...itaxel poliglumex,CT-2103) with gemcitabine or vi...tatus 2) patients with previously untreated non-sm...
Breaking Medicine Technology:Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5A search for protection against chemotherapy cardiotoxicity 1693 1A search for protection against chemotherapy cardiotoxicity 1693 2Certain diseases birth defects may be linked to failure of protein recycling system 1691 1Certain diseases birth defects may be linked to failure of protein recycling system 1691 2Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 1Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 1ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 3
...007 - Medtronic, Inc.,(NYSE:MDT) today announced ...l Trial indicates that the trial has met its prima...nical Trial is a randomized, single-blind,trial ev...M) Drug,Eluting Coronary Stent as compared to the ...m Boston Scientific Corporation,(NYSE:BSX). ENDEAV...
...rget from Lexicon,s Genetic,Research -, THE WOODLA...-,Lexicon Pharmaceuticals, Inc. today reported res...antibodies directed to a,potential new target, ang...triglycerides and cholesterol. Research suggests t...may have therapeutic,application in the treatment ...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: